Company Performance Metrics
- Henning Mork: CFOPast Role: Lytix Biopharma, Finance Manager
OstomyCure AS is a Medical Technology company with a headquarter in Oslo, Norway. The company develops a revolutionary technology called Transcutaneous Implant Evacuation System, The TIES® System.
The TIES® Continent Ileostomy System, is a titanium implant solution with a lid intended to replace a conventional ileostomy. It allows a more carefree
life for patients who suffer from inflammatory bowel diseases such as Crohn´s disease, Ulcerative colitis, multiple cancer or other related diseases that need the removal of the colon (large intestine).
The TIES® System is the result of several years of research combined with the latest 3D manufacturing technology, developed and produced in accordance with regulatory standards to ensure safety for the patients.
